Literature DB >> 16842214

The mechanism of plasmid curing in bacteria.

Gabriella Spengler1, Annamária Molnár, Zsuzsanna Schelz, Leonard Amaral, Derek Sharples, Joseph Molnár.   

Abstract

Bacterial plasmids have a major impact on metabolic function. Lactose fermentation of E. coli or hemolysin B transporter expressed by the plasmids that carry these respective genes could be readily obviated by heterocyclic compounds that readily bind to plasmid DNA. These compounds could also reverse the resistance to antibiotics of E. coli, Enterobacter, Proteus, Staphylococcus and Yersinia strains by eliminating plasmids. However, the frequency and extent of this effect was significantly less than might have been expected based on a complex interaction with plasmid DNA. The effects of heterocyclic compounds on the plasmids responsible for the virulence of Yersinia and A. tumefaciens, or on nodulation, nitrogen fixation of Rhizobia accounted for the elimination of 0.1 to 1.0 % of plasmids present in the populations studied. Bacterial plasmids can be eliminated from bacterial species grown as pure or mixed bacterial cultures in the presence of sub-inhibitory concentrations of non-mutagenic heterocyclic compounds. The antiplasmid action of the compounds depends on the chemical structure of amphiphillic compounds having a planar ring system with substitution in the L-molecular region. A symmetrical pi-electron conjugation at the highest occupied molecular orbitals favours the antiplasmid effect. The antiplasmid effect of heterocyclic compounds is expressed differentially in accordance with the structural form of the DNA to which they bind. In this manner "extrachromosomal" plasmid DNA that exists in a superhelical state binds more compound than its linear or open-circular form; and least to the chromosomal DNA of the bacterium, that carries the plasmid. It can also be noted that these compounds are not mutagenic and their antiplasmid effects correlate with the energy of HOMO-orbitals. Plasmid elimination is considered also to take place in ecosystems containing numerous bacterial species. This opens up a new perspective in rational drug design against bacterial plasmids. The inhibition of conjugational transfer of antibiotic resistance plasmid can be exploited to reduce the spread of antibiotic resistance plasmid in the ecosystem. Inhibition of plasmid replication at various stages, as shown in the "rolling circle" model (replication, partition, conjugal transfer) may also be the theoretical basis for the elimination of bacterial virulence in the case of plasmid mediated pathogenicity and antibiotic resistance. The large number of compounds tested for antiplasmid effects provides opportunities for QSAR studies in order to find a correlation between the antiplasmid effect and the supramolecular chemistry of these plasmid curing compounds. Plasmid elimination in vitro provides a method of isolating plasmid free bacteria for biotechnology without any risk of inducing mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842214     DOI: 10.2174/138945006777709601

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  23 in total

1.  Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.

Authors:  Scott A Lujan; Laura M Guogas; Heather Ragonese; Steven W Matson; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-13       Impact factor: 11.205

Review 2.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

3.  Plasmid mediated antibiotic resistance in isolated bacteria from burned patients.

Authors:  Fahimeh Beige; Majid Baseri Salehi; Nima Bahador; Sina Mobasherzadeh
Journal:  Jundishapur J Microbiol       Date:  2014-12-10       Impact factor: 0.747

4.  Assessment of Synthesis Machinery of Two Antimicrobial Peptides from Paenibacillus alvei NP75.

Authors:  Yogeswaran Jagadeesan; Selvamanikandan Athinarayanan; Sabeena Begum Mohamed Ayub; Anandaraj Balaiah
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

5.  Plasmid stability of potential probiotic Lactobacillus plantarum strains in artificial gastric juice, at elevated temperature, and in the presence of novobiocin and acriflavine.

Authors:  H Sağlam; A G Karahan
Journal:  Arch Microbiol       Date:  2020-08-16       Impact factor: 2.552

6.  Curing of plasmid pXO1 from Bacillus anthracis using plasmid incompatibility.

Authors:  Xiankai Liu; Dongshu Wang; Huagui Wang; Erling Feng; Li Zhu; Hengliang Wang
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

7.  Escherichia coli genes affecting recipient ability in plasmid conjugation: are there any?

Authors:  Daniel Pérez-Mendoza; Fernando de la Cruz
Journal:  BMC Genomics       Date:  2009-02-09       Impact factor: 3.969

8.  Anticonjugation and Antibiofilm Evaluation of Probiotic Strains Lactobacillus plantarum 22F, 25F, and Pediococcus acidilactici 72N Against Escherichia coli Harboring mcr-1 Gene.

Authors:  Prasert Apiwatsiri; Pawiya Pupa; Jitrapa Yindee; Waree Niyomtham; Wandee Sirichokchatchawan; Kittitat Lugsomya; Asad Ali Shah; Nuvee Prapasarakul
Journal:  Front Vet Sci       Date:  2021-06-11

9.  Evaluating targets for control of plasmid-mediated antimicrobial resistance in enteric commensals of beef cattle: a modelling approach.

Authors:  V V Volkova; Z Lu; C Lanzas; Y T Grohn
Journal:  Epidemiol Infect       Date:  2013-01-23       Impact factor: 4.434

Review 10.  An insight of traditional plasmid curing in Vibrio species.

Authors:  Vengadesh Letchumanan; Kok-Gan Chan; Learn-Han Lee
Journal:  Front Microbiol       Date:  2015-07-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.